MINDEN, Nev. - July 10, 2012 (Investorideas.com Newswire) Spare Backup Inc.(OTCBB: SPBU), a provider of data backup and security software for smartphones, tablets and PCs, which is carrier and manufacturer agnostic, today announced that Spare Backup has reduced its outstanding liabilities by approximately $1 million dollars in the third quarter of 2012 as management has begun an extensive review of certain accounts payable and other obligations of the company. Management believes there will be additional reductions in overall liabilities including the elimination of certain aged payables and renegotiation of others which will help to strengthen its balance sheet in the coming quarters.

MINDEN, Nev. - July 9, 2012 (Investorideas.com Newswire) Tech stock news: Spare Backup Inc. (OTCBB: SPBU), a provider of data backup and security software for smartphones, tablets and PCs, which is carrier and manufacturer agnostic, today announced that it plans to launch Spare's mobile security and data backup services with a second financial services group in Europe as part of the master services agreement with our largest European distribution partner. Spare mobile services will be incorporated as part of various insurance and warranty packages offered by the financial services group.

Gold Bullion Development Corp. (TSXV: GBB, OTC PINK: GBBFF) (the "Company" or "Gold Bullion") is pleased to announce preliminary drill results from holes and wedge holes located to the north of the existing mineralized area of the Granada Gold Property. The subject property is located along the prolific Cadillac trend in North-western Quebec, 5 km south of the city of Rouyn-Noranda.

Frank Basa, Gold Bullion's CEO, is very encouraged by results that consistently demonstrate the presence of widespread significant gold on the Granada property. Hole DUP-12-02 intercepted 4.15 grams Au per tonne over a 3 metre core length at 615 metres and 4.58 grams per tonne Au over 3 metres at 995 metres depth.

New York, New York - July 9, 2012 - Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a report on biotech companies targeting aggressive forms of cancer; Roche's (SIX: RO, ROG; OTCQX: RHHBY) Herceptin® cancer drug and Sunshine Biopharma Inc. (OTCBB: SBFM) with its lead compound, Adva-27a.

 Roche is the largest biotech company in the world and Sunshine Biopharma is a small microcap biopharma company. The two genes associated with aggressive forms of cancer are Her2 and Top2; Roche is targeting Her2-Positive patients and Sunshine Biopharma is targeting multidrug resistant Top2, which has no current effective drugs in the market for patients.